Allergan Treatment Approved by FDA

Allergan Inc. said Monday that the U.S. Food and Drug Administration has approved the marketing of the company’s Alocril solution for the treatment of itch associated with allergic conjunctivitis. Allergan expects to launch the product by March.

“The approval of Alocril provides an important new option for the treatment of a common ocular disorder,” said Dr. Lester J. Kaplan, who heads the Irvine eye care company’s research and development. “This technology provides Allergan with an opportunity to further penetrate a rapidly growing segment of the ophthalmic market.”